Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK HRV vaccine in healthy infants in South Africa
NCT00383903Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2003
- Primary completion
- Sep 2004
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of rotavirus vaccine, live, oral in rotavirus infection (3 arms), sponsored by GSK. Primary endpoint: Seroconversion after HRV vaccination. Started Sep 2003; status: completed.
02
Drugs
rotavirus vaccine, live, oral
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT00383903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383903.